Steven W. Barger

10.3k total citations · 2 hit papers
111 papers, 8.5k citations indexed

About

Steven W. Barger is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Steven W. Barger has authored 111 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 52 papers in Physiology and 28 papers in Cellular and Molecular Neuroscience. Recurrent topics in Steven W. Barger's work include Alzheimer's disease research and treatments (50 papers), Neuroinflammation and Neurodegeneration Mechanisms (25 papers) and Neuroscience and Neuropharmacology Research (18 papers). Steven W. Barger is often cited by papers focused on Alzheimer's disease research and treatments (50 papers), Neuroinflammation and Neurodegeneration Mechanisms (25 papers) and Neuroscience and Neuropharmacology Research (18 papers). Steven W. Barger collaborates with scholars based in United States, China and Canada. Steven W. Barger's co-authors include Mark P. Mattson, Linda J. Van Eldik, W. Sue T. Griffin, Ling Liu, Anthony S. Basile, Xianrong Mao, Angela M. Bodles, Robert J. Mark, Koichi Furukawa and Katsutoshi Furukawa and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Steven W. Barger

108 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E

1997 522 citations Steven W. Barger et al. Nature profile →
Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

1995 515 citations Steven W. Barger, Mark P. Mattson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven W. Barger United States	45	3.9k	3.3k	2.4k	2.1k	977	111	8.5k
Magdalena Sastre United Kingdom	51	3.8k 1.0×	4.2k 1.3×	2.6k 1.1×	2.3k 1.1×	576 0.6×	99	9.1k
Luisa Minghetti Italy	56	3.0k 0.8×	1.5k 0.5×	3.0k 1.3×	1.5k 0.7×	1.5k 1.5×	138	8.2k
Elena Galea United States	43	2.4k 0.6×	2.4k 0.7×	2.0k 0.8×	1.7k 0.8×	730 0.7×	77	6.0k
Simonetta Camandola United States	43	3.5k 0.9×	2.3k 0.7×	1.3k 0.5×	1.1k 0.5×	963 1.0×	77	8.1k
Ángeles Almeida Spain	47	4.5k 1.2×	2.1k 0.6×	1.5k 0.6×	1.7k 0.8×	459 0.5×	112	8.0k
Maria Mańczak United States	40	5.5k 1.4×	4.9k 1.5×	894 0.4×	1.8k 0.9×	442 0.5×	85	8.9k
Jeroen J.M. Hoozemans Netherlands	55	3.6k 0.9×	4.4k 1.3×	2.6k 1.1×	1.6k 0.8×	527 0.5×	172	9.8k
Colin K. Combs United States	46	2.5k 0.6×	3.0k 0.9×	2.8k 1.2×	1.7k 0.8×	862 0.9×	101	7.4k
Maria Ankarcrona Sweden	36	4.9k 1.3×	2.8k 0.9×	777 0.3×	2.2k 1.0×	466 0.5×	70	8.0k
Robert Veerhuis Netherlands	49	2.3k 0.6×	3.5k 1.1×	2.8k 1.2×	862 0.4×	928 0.9×	126	7.0k

Countries citing papers authored by Steven W. Barger

Since Specialization

Citations

This map shows the geographic impact of Steven W. Barger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven W. Barger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven W. Barger more than expected).

Fields of papers citing papers by Steven W. Barger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven W. Barger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven W. Barger. The network helps show where Steven W. Barger may publish in the future.

Co-authorship network of co-authors of Steven W. Barger

This figure shows the co-authorship network connecting the top 25 collaborators of Steven W. Barger. A scholar is included among the top collaborators of Steven W. Barger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven W. Barger. Steven W. Barger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagel, Corey, et al.. (2025). Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study. Journal of Alzheimer s Disease. 106(3). 1063–1073. 1 indexed citations

Li, Qingyou, A. Moerman, Steven W. Barger, et al.. (2023). Central repeat fragment of reelin leads to active reelin intracellular signaling and rescues cognitive deficits in a mouse model of reelin deficiency. Cellular Signalling. 109. 110763–110763. 4 indexed citations

Deng, Juan, Ahsan Habib, Demian Obregon, et al.. (2015). Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway. Journal of Neurochemistry. 135(3). 630–637. 62 indexed citations

Hou, Huayan, Min Ji Song, Demian Obregon, et al.. (2013). GFAP expression and social deficits in transgenic mice overexpressing human sAPPα. Glia. 61(9). 1556–1569. 25 indexed citations

Thompson, Misty M., John C. Marecki, Stéphane Marinesco, et al.. (2011). Paradoxical roles of serine racemase and d‐serine in the G93A mSOD1 mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry. 120(4). 598–610. 24 indexed citations

Labrie, Viviane, Ryutaro Fukumura, Laura J. Fick, et al.. (2009). Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Human Molecular Genetics. 18(17). 3227–3243. 140 indexed citations

Barger, Steven W., et al.. (2009). Genetic loss of D‐amino acid oxidase activity reverses schizophrenia‐like phenotypes in mice. Genes Brain & Behavior. 9(1). 11–25. 44 indexed citations

Barger, Steven W., et al.. (2007). Glycogen Synthase Kinase-3 in Neurodegeneration and Neuroprotection:Lessons from Lithium. Current Alzheimer Research. 4(1). 21–31. 53 indexed citations

Barger, Steven W., et al.. (2007). Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. Journal of Neurochemistry. 101(5). 1205–1213. 199 indexed citations

10.

Griffin, W. Sue T., et al.. (2006). Interleukin-1 mediates Alzheimer and Lewy body pathologies. Journal of Neuroinflammation. 3(1). 5–5. 207 indexed citations

11.

Wu, Shengzhou, Shujun Jiang, Terry J. Sims, & Steven W. Barger. (2005). Schwann cells exhibit excitotoxicity consistent with release of NMDA receptor agonists. Journal of Neuroscience Research. 79(5). 638–643. 22 indexed citations

12.

Barger, Steven W.. (2004). An unconventional hypothesis of oxidation in alzheimer's disease: intersections with excitotoxicity. Frontiers in bioscience. 9(1-3). 3286–3286. 22 indexed citations

13.

Liu, Ling, et al.. (2004). S100B‐induced microglial and neuronal IL‐1 expression is mediated by cell type‐specific transcription factors. Journal of Neurochemistry. 92(3). 546–553. 86 indexed citations

14.

Liu, Ling, et al.. (2003). Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway. Journal of Neuroscience. 23(5). 1605–1611. 445 indexed citations

15.

Mao, Xianrong, A. Moerman, & Steven W. Barger. (2002). Neuronal κB-binding Factors Consist of Sp1-related Proteins. Journal of Biological Chemistry. 277(47). 44911–44919. 33 indexed citations

16.

Mao, Xianrong & Steven W. Barger. (1998). Neuroprotection by dehydroepiandrosteronesulfate. Neuroreport. 9(4). 759–763. 93 indexed citations

17.

Barger, Steven W., et al.. (1997). Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 388(6645). 878–881. 522 indexed citations breakdown →

18.

Barger, Steven W. & Mark P. Mattson. (1997). Isoform‐Specific Modulation by Apolipoprotein E of the Activities of Secreted β‐Amyloid Precursor Protein. Journal of Neurochemistry. 69(1). 60–67. 40 indexed citations

19.

Toborek, Michał, Steven W. Barger, Mark P. Mattson, Craig J. McClain, & Bernhard Hennig. (1995). Role of glutathione redox cycle in TNF-α-mediated endothelial cell dysfunction. Atherosclerosis. 117(2). 179–188. 60 indexed citations

20.

Eldik, Linda J. Van, Steven W. Barger, & Michael J. Welsh. (1992). Antisense Approaches to the Function of Glial Cell Proteinsa. Annals of the New York Academy of Sciences. 660(1). 219–230. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact